FDA Recalls Two More Eye Drop Brands Due to Risks

HI INDIA NEWS DESK
WASHINGTON, DC- The US Food and Drug Administration (FDA) has issued alerts about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury. The recall notices were posted for certain eyedrops distributed by Pharmedica and Apotex after the companies voluntarily pulled several lots of their products from the market.

Pharmedica has recalled two lots of Purely Soothing 15% MSM Drops due to problems that “could result in blindness”. The over-the-counter drops are designed to treat eye irritation and consumers are advised to stop using the product and return it to the place of purchase.

Apotex has recalled six lots of prescription eyedrops used to treat glaucoma. The recall was initiated after cracks were found in some bottle caps. The drops are distributed as Brimonidine Tartrate Ophthalmic Solution 0.15% and were sold between April 2022 and February 2023.

Both recalls were conducted in consultation with the FDA. Company representatives were not immediately available for comment.

These recalls follow a recall last month of eyedrops made in India that were linked to an outbreak of drug-resistant infections, resulting in one death and at least five cases of permanent vision loss. There is no indication that these latest recalls are related to that product.